Скачать или смотреть Are we undertreating aortic regurgitation? - EuroPCR 2025

At #europcr 2025, Victoria Delgado, Helge Möllmann, and Dan Blackman come together to address an often-overlooked issue: the under-referral and under-treatment of patients with aortic regurgitation (AR).

Why is diagnosing severe AR still such a challenge? And even when diagnosed, why are only 25–30% of these patients receiving surgical aortic valve replacement? The discussion highlights the need to distinguish between younger and older patients—while mechanical valve replacement is an option for younger individuals, treatment options for elderly patients remain limited.

With the arrival of dedicated TAVI devices for AR, such as the JenaValve Trilogy System, the panel reviews the latest data and considers whether awareness of these options is widespread enough among practitioners.

How can access to treatment be improved? What does the current evidence tell us?
This round table starts answering these key questions—watch the full conversation now.

Supported by JenaValve

More videos on PCRonline: https://www.pcronline.com/Cases-resou...

#aorticregurgitation, #savr, #tavi